Rituximab induces sustained reduction of pathogenic B cells in patients with peripheral nervous system autoimmunity.

Maurer MA, Rakocevic G, Leung CS, Quast I, Lukacišin M, Goebels N, Münz C, Wardemann H, Dalakas M, Lünemann JD. Rituximab induces sustained reduction of pathogenic B cells in patients with peripheral nervous system autoimmunity. J Clin Invest. 2012 Apr 2; 122(4):1393-402.

View in: PubMed